| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e04a9c30b01a6909696dc92e883f241c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_55eca0edf9b48342dfc1406c9dfd5bd4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57488 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate |
2008-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3f200d91b37bedc2604e957021b07c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5382f4e663840d22f4f6129acff336d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_516e8af80f3df0e2294102f7a39b6eed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_543c569bfe8652646c1542bf54290b88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_936a582513f614c9ac958324ee014289
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10f1d51fb00017eecf203b676922cd8d |
| publicationDate |
2010-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2172218-A1 |
| titleOfInvention |
Method for screening of patient to be administered with pharmaceutical agent comprising anti-cancer antibody as active ingredient |
| abstract |
The present invention provides a method for screening a patient to be administered with a pharmaceutical composition which comprises an anti-cancer antibody as an active ingredient, said method comprising collecting samples from patients who expresses an antigen which is recognized by the anti-cancer antibody, measuring cadherin function in the samples, and selecting a patient whose the cadherin function is decreased or deleted; a method for screening a patient who has a high efficacy ratio for a pharmaceutical composition which comprises an anti-cancer antibody as an active ingredient; and a method for improving an efficacy ratio for a pharmaceutical composition which comprises an anti-cancer antibody as an active ingredient. |
| priorityDate |
2007-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |